Business Wire

Jumbo Supermarkten Selects Quintiq to Optimize its Complex Supply Chain

Del

Quintiq, a Dassault Systèmes company and global leader in supply chain planning and optimization (SCP&O), announces that it has been selected to further optimize Jumbo Supermarkten’s supply chain. The fastest growing supermarket chain in the Netherlands, Jumbo is on a mission to provide outstanding service and products at the lowest prices, exceeding customer expectations every day.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180313005702/en/

Supermarket chain Jumbo selects Quintiq to optimize end-to-end supply chain (Photo: Business Wire)

Supermarket chain Jumbo selects Quintiq to optimize end-to-end supply chain (Photo: Business Wire)

This mission is well supported by Quintiq’s optimization technology. The Quintiq solution will efficiently plan Jumbo’s transport and warehouse capacities. Jumbo’s supply chain involves 10 distribution centers, almost 600 stores and about 500 owned and chartered trucks. The scope covers the planning of store distribution, home deliveries, inbound operations, backhauls for all channels and logistics between distribution centers. With a planning solution that integrates with existing systems, Jumbo will gain full transparency of its supply chain.

“We’ve found the right technology partner to help us plan and control our supply chain,” said Karel de Jong, director of supply chain at Jumbo. “Quintiq provides us with integrated supply chain management, an approach that is demand-driven and optimized based on Jumbo’s business goals and constraints.”

There’s a wide range of other requirements and constraints that comes with supply chain planning. The Quintiq solution is intelligent enough to take them into account while improving Jumbo’s delivery performance, cost savings and planning flexibility. Jumbo’s constraints include store opening times, specific timeframes for deliveries, amount of employees and shifts and different temperature compartments in vehicles. The solution will also take into account regulatory constraints such as restrictions when transporting fresh produce, as well as legal rules in terms of truck drivers’ working hours. With Quintiq’s optimized planning, Jumbo will be able to achieve more sustainable operations through reducing their carbon footprint.

The solution will be used for Jumbo’s logistics planning on tactical, operational and day-of-execution levels. Using scenario-based tactical planning, Jumbo will be able to evaluate all possible options against specific KPIs. For operational planning, Quintiq takes into account the latest order volume and resource capacity for optimized plans up to one week ahead. On the day of execution, the solution ensures smooth-running movements based on confirmed orders and supports planners in managing disruptions effectively. The latter is enabled by real-time monitoring of execution, which provides visibility of both resources and charter resources in terms of trip progress, traffic and disruptions.

“Jumbo has a large, complex supply chain that's rapidly growing. Optimized planning is key to reaching its full potential,” said Rob van Egmond, CEO at Quintiq. “This is where Quintiq comes in. We’re able to provide real-time insights that help Jumbo make the right logistics decisions swiftly. This enables Jumbo to improve on-shelf availability and increase customer satisfaction.”

About Jumbo Supermarkten

Jumbo currently has over 580 shops, of which three are food markets. Additionally, the supermarket chain has 390 pick-up points for online orders and a home delivery service. The unique Jumbo formula (best service with largest assortment at lowest prices) applies to all of its shops and online store. Customers can rely on Jumbo’s brand promise of 7 Certainties. By putting the customer at the heart of its business, the family-owned company has become one of the fastest growing supermarkets in the Netherlands. After taking over Super de Boer in 2009 and C1000 in 2012, Jumbo became the second largest grocery chain in the country. Additionally, Jumbo took over the La Place restaurant chain in 2016.For more information, visit jumbo.com.

About Quintiq

Every business has its supply chain planning challenges. Some of those challenges are large, some are complex and some seem impossible to solve. Since 1997, Quintiq has been solving each of those challenges using a single supply chain planning and optimization software. Today, industry-leading companies across the globe rely on Quintiq software to plan and optimize workforces, logistics and production. Quintiq is part of Dassault Systèmes (Euronext Paris: #13065, DSY.PA) and has headquarters in the Netherlands and the USA, and offices around the world.

For more information, visit quintiq.com or follow Quintiq on Twitter, Facebook, LinkedIn and YouTube.

Contact information

North America Enquiries
Caitlin Noah
Quintiq
Tel: +1 484 586 3232
caitlin.noah@3ds.com
or
EMEA Enquiries
Richard Ratcliffe
Weber Shandwick
+44 207 067 0846
quintiq@webershandwick.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10Pressemelding

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13Pressemelding

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00Pressemelding

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41Pressemelding

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00Pressemelding

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i

Announcement by Viking Corp on Tecnotree22.6.2018 11:09Pressemelding

In the interests of stakeholder transparency, this announcement provides background and context to Viking's file bankruptcy proceedings upon Tecnotree: As many of you will now know, Viking Corp was recently forced to file bankruptcy proceedings upon Tecnotree, which were withdrawn on the 19 June. In the interests of stakeholder transparency, we make this Announcement to provide background and context to this action. Firstly, we would reflect on the recent history of our attempts to partner with Tecnotree and all its stakeholders. Viking launched a Tender Offer (TO), having conducted detailed discussions with the Tecnotree Board and our advisors. On the basis of those discussions, we were very confident that the TO price of 10 cents per share provided truly superior value for shareholders. So did the Tecnotree Board as evidenced by their unanimous recommendation of our Offer and of course, further evidenced by the current prevailing market price. This TO was supported in the most vigoro